<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:DOC-C2GXGS2J</identifier><date>1996</date><creator>Hödl, S...</creator><creator>Kerl, H...</creator><creator>Müllegger, R... R.</creator><creator>Schlüpen, E... M.</creator><creator>Soyer, H... P.</creator><creator>Volkenandt, M...</creator><creator>Wienecke, R...</creator><creator>Zöchling, N...</creator><relation>documents/doc/C/URN_NBN_SI_doc-C2GXGS2J_001.pdf</relation><relation>documents/doc/C/URN_NBN_SI_doc-C2GXGS2J_001.txt</relation><format format_type="issue">3-4</format><format format_type="volume">5</format><format format_type="type">article</format><format format_type="extent">str. 163-168</format><identifier identifier_type="ISSN">1318-4458</identifier><identifier identifier_type="COBISSID_HOST">5116121</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-C2GXGS2J</identifier><language>eng</language><publisher publisher_location="Ljubljana">Slovene Welding Society</publisher><source>Acta dermatovenerologica Alpina, Pannonica et Adriatica</source><rights>InC</rights><subject language_type_id="slv">Adverse effects</subject><subject language_type_id="slv">Borrelia burgdorferi</subject><subject language_type_id="slv">Diagnosis</subject><subject language_type_id="slv">Drug therapy</subject><subject language_type_id="slv">Follow-up studies</subject><subject language_type_id="slv">Isolation and purification</subject><subject language_type_id="slv">Lyme disease</subject><subject language_type_id="slv">Middle age</subject><subject language_type_id="slv">Minocycline</subject><subject language_type_id="slv">Therapeutic use</subject><title>Minocycline in early Lyme borreliosis</title></Record>